Edenred: back in the black, broker reiterates its recommendation
The service and payment platform announced total revenues of 685 million euros for the first quarter of 2024, up 21.4% (+20.5% on a comparable basis).
Following this announcement, UBS has reiterated its Buy recommendation on the share and left its price target unchanged at E72, which represents a potential upside of 55%.
' Edenred posted solid results in the first quarter, with an increase in operating sales (+17%) and accelerating growth in Latin America (+22%)' says UBS.
Confident in maintaining a sustained pace of growth, Edenred confirms for 2024 the objectives of its Beyond 22-25 plan, namely organic EBITDA growth of over 12% and a FCF/EBITDA conversion rate of over 70%.
Copyright (c) 2024 CercleFinance.com. All rights reserved.
Go to the original article.
Contact us to request a correction